SCHEMBL6892858

SCHEMBL6892858

NC(Cc1ccccc1)C(O)CNCc1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP2D6 P10635 1/20 0.53
BCHE P06276 1/20 0.48
ALDH1A1 P00352 3/20 0.48
NPSR1 Q6W5P4 1/20 0.48
LTA4H P09960 1/20 0.47
CHRM2 P08172 1/20 0.46
HTT P42858 2/20 0.45
KEAP1 Q14145 1/20 0.45
RECQL P46063 1/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3355705 1.00 CYP1A2 (0.53) CYP1A2CYP2D6BCHEALDH1A1NPSR1
SCHEMBL4042114 0.87 ANPEP (0.46) SMN1; SMN2
SCHEMBL3348009 0.86 CYP1A2 (0.47) CYP1A2CYP2D6ALDH1A1NPSR1CHRM2
SCHEMBL6887793 0.86 BCHE (0.53) BCHEALDH1A1LMNACYP3A4GAA
SCHEMBL3382581 0.86 BCHE (0.53) BCHEALDH1A1LMNACYP3A4GAA
SCHEMBL496172 0.85 BCHE (0.61) CYP1A2CYP2D6BCHEALDH1A1LMNA
SCHEMBL7951036 0.85 BCHE (0.61) CYP1A2CYP2D6BCHEALDH1A1LMNA
SCHEMBL3353939 0.85 BCHE (0.61) CYP1A2CYP2D6BCHEALDH1A1LMNA
SCHEMBL2605624 0.85 BCHE (0.61) CYP1A2CYP2D6BCHEALDH1A1LMNA
Hydrochloric Acid SCHEMBL5225060 0.84 BCHE (0.60) CYP1A2CYP2D6BCHEALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed